The aberrant expressions of Piezo1/2 are either positively or negatively correlated with patient survival in a variety of cancer types, implicating that Piezo1/2 show either oncogenic or tumor suppressive functions, likely depending on cancer type and subtype [243]. The gene discussed is PIEZO1; the disease is cancer.